?one prior program of chemotherapy for Sophisticated breast most cancers and across the whole trial, former exposure to any FGFR inhibitor, important surgical procedures or radiotherapy inside 4 weeks before initially dose of review therapy and taking potent inhibitors or inducers of CYP3A4 or CYP2D6. Any of the following cardiac criteria precluded